Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262,005 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of dexamethasone and a 5-HT3 receptor antagonist with or without aprepitant to prevent chemotherapy-induced nausea and vomiting among patients with lung cancer who are treated with platinum-based chemotherapy: a systematic review and meta-analysis of randomized controlled trials.
He M, Xu R, Liu M, Zhang Y, Yi F, Wei Y, Liu Q, Zhang W. He M, et al. Among authors: zhang w, zhang y. Ann Palliat Med. 2021 Apr;10(4):4308-4319. doi: 10.21037/apm-20-2290. Epub 2021 Apr 15. Ann Palliat Med. 2021. PMID: 33894731 Free article.
The benefits and risks of pembrolizumab in combination with chemotherapy as first-line therapy in small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized control trials.
Liu Q, Zhang Y, Liu M, Xu R, Yi F, Wei Y, Zhu S, Zhang W. Liu Q, et al. Among authors: zhang w, zhang y. World J Surg Oncol. 2021 Oct 14;19(1):298. doi: 10.1186/s12957-021-02410-3. World J Surg Oncol. 2021. PMID: 34645484 Free PMC article. Review.
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets.
You M, Xie Z, Zhang N, Zhang Y, Xiao D, Liu S, Zhuang W, Li L, Tao Y. You M, et al. Among authors: zhang n, zhang y. Signal Transduct Target Ther. 2023 May 10;8(1):196. doi: 10.1038/s41392-023-01442-3. Signal Transduct Target Ther. 2023. PMID: 37164974 Free PMC article. Review.
PRIMARY CUTANEOUS CD8+ AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA WITH NOVEL FGFR1 FUSION TREATED WITH PEMIGATINIB.
Torres-Cabala CA, Yescas J, Zhang Y, Huen A, Gaur S, Tefft K, Tang G, Curry JL, Gunther JR, Dabaja BS, Iyer SP, Miranda RN, Choi J, Nardi V. Torres-Cabala CA, et al. Among authors: zhang y. Blood Adv. 2025 Jan 18:bloodadvances.2024014928. doi: 10.1182/bloodadvances.2024014928. Online ahead of print. Blood Adv. 2025. PMID: 39825823 No abstract available.
262,005 results
You have reached the last available page of results. Please see the User Guide for more information.